Skip to content
healthcare.dev

Terazosin

NDC 27241-289, Terazosin, capsule, from Ajanta Pharma USA Inc..

Product NDC
27241-289
Status
Listed
Labeler
Ajanta Pharma USA Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219482
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/27241-289 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERAZOSIN HYDROCHLORIDE2 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
27241-289-0127241028901100 CAPSULE in 1 BOTTLE (27241-289-01)
27241-289-10272410289101000 CAPSULE in 1 BOTTLE (27241-289-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bed99c2a-4266-4a2c-bb0f-7643fdafff78
  • NADAC price for package 27241028901

    GET /v1/drugs/nadac/27241028901

Use it

Look up 27241-289 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/27241-289 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 27241-289. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.